Latest filing published 03 May 2016 for Navidea Biopharmaceuticals, INC..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gordon A. Troup: trading record in brief
Gordon A. Troup discloses dealings in Navidea Biopharmaceuticals, Inc. to SEC (Form 4). We count 20 filings; the first trade dates from 12 September 2008 and the latest from 20 April 2016.
Every open-market trade on record is a purchase: 10 purchases worth €117k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 10 share grants.
A typical purchase (the median) is worth €12k.
The latest filing, published on 3 May 2016, reports a share grant in Navidea Biopharmaceuticals, Inc. The latest purchase dates back some time: it was published 4,179 days ago, on 1 June 2015. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gordon A. Troup
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 28,000 shares0Common StockSEC:0001144204-16-098705:0
- 5,254 shares@ US$2.24Common StockSEC:0001638599-15-000267:0
- 10,559 shares@ US$1.61Common StockSEC:0001144204-15-044519:0
- 10,000 shares@ US$1.31Common StockSEC:0001144204-15-034708:0Canonical exit: 27 Aug 2015 (T+90)
- 22,000 shares0Common StockSEC:0001144204-15-019369:0
- 7,406 shares@ US$1.89Common StockSEC:0001144204-15-006971:0
- 16,099 shares@ US$1.32Common StockSEC:0001144204-14-066951:0
- 20,000 shares0Common StockSEC:0001225208-14-004936:0
- 20,000 shares@ US$1.36Common StockSEC:0001225208-13-023151:0Canonical exit: 6 Feb 2014 (T+90)
- 7,000 shares@ US$2.70Common StockSEC:0001225208-13-007845:0Canonical exit: 13 Jun 2013 (T+90)
- 30,000 shares0Common StockSEC:0001225208-13-007801:0
- 12,250 shares0Common StockSEC:0001225208-13-005556:0
- 5,000 shares@ US$3.58Common StockSEC:0001225208-12-019561:0Canonical exit: 13 Nov 2012 (T+90)
- 5,000 shares@ US$2.64Common StockSEC:0001225208-12-019561:1Canonical exit: 11 Dec 2012 (T+90)
- 17,000 shares0Common StockSEC:0001225208-12-009634:0
- 10,000 shares@ US$2.61Common StockSEC:0001225208-11-020384:0Canonical exit: 20 Nov 2011 (T+90)
- 10,000 shares@ US$1.75Common StockSEC:0001225208-10-025146:0Canonical exit: 13 Feb 2011 (T+90)
- 11,500 shares@ US$0.70Common StockSEC:0001225208-09-022036:0Canonical exit: 18 Aug 2009 (T+90)
- 3,500 shares@ US$0.68Common StockSEC:0001225208-09-022036:1Canonical exit: 18 Aug 2009 (T+90)
- 15,000 shares@ US$0.68Common StockSEC:0001225208-08-014839:0Canonical exit: 11 Dec 2008 (T+90)
20 of 20 declarations